Kymera Therapeutics (KYMR) PT Raised to $140 at JPMorgan
Tweet
Share
E-mailGet Alerts KYMR Hot Sheet
Price: $117.00 +1.36%
Rating Summary:
27 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 14 | New: 59
Rating Summary:
27 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 14 | New: 59
Join SI Premium – FREE
JPMorgan analyst Brian Cheng raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $140.00 (from $121.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Kymera Therapeutics (KYMR) to Outperform
- The Lovesac Co. (LOVE) PT Lowered to $20 at Canaccord
- Sony Corp. (6758:JP) (SNE) PT Raised to JPY4,700 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
